Firebrick Pharma Limited ( (AU:FRE) ) has issued an update.
Firebrick Pharma Limited has announced the quotation of 189,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of March 28, 2025. This move reflects the company’s efforts to enhance its financial standing and market presence, potentially impacting its operations and stakeholder interests positively.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of innovative healthcare products.
YTD Price Performance: 50.0%
Average Trading Volume: 201,606
Technical Sentiment Signal: Sell
See more data about FRE stock on TipRanks’ Stock Analysis page.